Mitral regurgitation severity at left ventricular assist device implantation is associated with distinct myocardial transcriptomic signatures

被引:5
作者
Duggal, Neal M. [1 ]
Lei, Ienglam [2 ]
Wu, Xiaoting [2 ]
Aaronson, Keith D. [3 ]
Pagani, Francis D. [2 ]
Lam, Hugo Y. -K. [4 ]
Tang, Paul C. [2 ]
机构
[1] Univ Michigan, Frankel Cardiovasc Ctr, Dept Anesthesiol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Frankel Cardiovasc Ctr, Dept Cardiac Surg, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Frankel Cardiovasc Ctr, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA
[4] HypaHub Inc, San Jose, CA USA
基金
英国工程与自然科学研究理事会;
关键词
heart failure; mitral regurgitation; left ventric-ular assist device; transcriptomics; outcomes; HEART-FAILURE; EXTRACELLULAR-MATRIX; POTENTIAL ROLE; VALVE REPAIR; INFLAMMATION; EXPRESSION; DYSFUNCTION; ACTIVATION; BIOMARKERS; SUPPORT;
D O I
10.1016/j.jtcvs.2021.08.061
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: We examined for differences in pre-left ventricular assist device (LVAD) implantation myocardial transcriptome signatures among patients with different degrees of mitral regurgitation (MR).Methods: Between January 2018 and October 2019, we collected left ventricular (LV) cores during durable LVAD implantation (n = 72). A retrospective chart review was performed. Total RNA was isolated from LV cores and used to construct cDNA sequence libraries. The libraries were sequenced with the NovaSeq system, and data were quantified using Kallisto. Gene Set Enrichment Analysis (GSEA) and Gene Ontology analyses were performed, with a false discovery rate<0.05 consid-ered significant.Results: Comparing patients with preoperative mild or less MR (n = 30) and those with moderate-severe MR (n = 42), the moderate-severe MR group weighted less (P = .004) and had more tricuspid valve repairs (P = .043), without differences in demographics or comorbidities. We then compared both groups with a group of human donor hearts without heart failure (n = 8). Compared with the donor hearts, there were 3985 differentially expressed genes (DEGs) for mild or less MR and 4587 DEGs for moderate-severe MR. Specifically altered genes included 448 DEGs for specific for mild or less MR and 1050 DEGs for moderate-severe MR. On GSEA, com-mon regulated genes showed increased immune gene expression and reduced expression of contraction and energetic genes. Of the 1050 genes specific for moderate-severe MR, there were additional up-regulated genes related to inflam-mation and reduced expression of genes related to cellular proliferation.Conclusions: Patients undergoing durable LVAD implantation with moderate -severe MR had increased activation of genes related to inflammation and reduction of cellular proliferation genes. This may have important implications for myocardial recovery. (J Thorac Cardiovasc Surg 2023;166:141-52)
引用
收藏
页码:141 / 152.e1
页数:13
相关论文
共 62 条
  • [1] Reappraising the role of inflammation in heart failure
    Adamo, Luigi
    Rocha-Resende, Cibele
    Prabhu, Sumanth D.
    Mann, Douglas L.
    [J]. NATURE REVIEWS CARDIOLOGY, 2020, 17 (05) : 269 - 285
  • [2] The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart
    Altara, Raffaele
    Mallat, Ziad
    Booz, George W.
    Zouein, Fouad A.
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [3] CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study
    Altara, Raffaele
    Manca, Marco
    Hessel, Marleen H.
    Gu, Yumei
    van Vark, Laura C.
    Akkerhuis, K. Martijn
    Staessen, Jan A.
    Struijker-Boudier, Harry A. J.
    Booz, George W.
    Blankesteijn, W. Matthijs
    [J]. JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2016, 9 (04) : 302 - 314
  • [4] Outcomes of patients after successful left ventricular assist device explantation: a EUROMACS study
    Antonides, Christiaan F. J.
    Schoenrath, Felix
    de By, Theo M. M. H.
    Muslem, Rahatullah
    Veen, Kevin
    Yalcin, Yunus C.
    Netuka, Ivan
    Gummert, Jan
    Potapov, Evgenij V.
    Meyns, Bart
    Ozbaran, Mustafa
    Schibilsky, David
    Caliskan, Kadir
    [J]. ESC HEART FAILURE, 2020, 7 (03): : 1085 - 1094
  • [5] Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure
    Barton, PJR
    Birks, EJ
    Felkin, LE
    Cullen, ME
    Koban, MU
    Yacoub, MH
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (07) : 738 - 744
  • [6] Inflammation versus mechanical stretch biomarkers over time in acutely decompensated heart failure with reduced ejection fraction
    Boulogne, M.
    Sadoune, M.
    Launay, J. M.
    Baudet, M.
    Cohen-Solal, A.
    Logeart, D.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 226 : 53 - 59
  • [7] Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis
    Cordero-Reyes, Andrea M.
    Youker, Keith A.
    Trevino, Alejandro R.
    Celis, Rene
    Hamilton, Dale J.
    Flores-Arredondo, Jose H.
    Orrego, Carlos M.
    Bhimaraj, Arvind
    Estep, Jerry D.
    Torre-Amione, Guillermo
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (01): : 1 - 12
  • [8] Cordero-Reyes Andrea M, 2013, Methodist Debakey Cardiovasc J, V9, P15
  • [9] Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade
    Dandona, P.
    Dhindsa, S.
    Ghanim, H.
    Chaudhuri, A.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2007, 21 (01) : 20 - 27
  • [10] Chronic Heart Failure and Inflammation What Do We Really Know?
    Dick, Sarah A.
    Epelman, Slava
    [J]. CIRCULATION RESEARCH, 2016, 119 (01) : 159 - 176